![](https://www.bioworld.com/ext/resources/Stock-images/Money/Financial-line-graph.jpg?height=635&t=1707863338&width=1200)
Biopharma index outpaces market benchmarks with an 8% rise
The BioWorld Biopharmaceutical Index (BBI) saw an 8.15% increase at the close of May, outperforming the Dow Jones Industrial Average, which rose by 2.64%, and the Nasdaq Biotechnology Index, which was up by 0.7%. The BBI previously showed a strong …